CASEY MEEKS: Open Payments
NPI 1013300045 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 73 payments from 38 companies in 2025. Trend: 2023 $2,152 · 2024 $953 · 2025 $1,874
Food & beverage: $1,874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $241 |
| Novartis Pharmaceuticals Corporation | 9 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $110 |
| GENZYME CORPORATION | 2 | $94 |
| PharmaEssentia USA Corporation | 3 | $74 |
| Merck Sharp & Dohme LLC | 2 | $60 |
| Janssen Biotech, Inc. | 3 | $58 |
| Exelixis Inc. | 2 | $50 |
| Fennec Pharmaceuticals, Inc. | 3 | $49 |
Products named: IMFINZI, Nubeqa, LIBTAYO, SCEMBLIX, KISQALI, BESREMI, SARCLISA, EPKINLY.
Industry payments across TN — which companies pay providers there.
